Relationship Between Transabdominal Measurements of Prostate Volume and Anthropometric Measurements among Male Residents in Ondo State
DOI:
https://doi.org/10.14738/jbemi.96.13354Abstract
Introduction: The prostate gland is a major site of diseases like prostatitis, benign prostatic hyperplasia and carcinoma of the prostate. Growth and enlargement of prostate can be predicted by prostate volume in the future. The prostate gland volume are influenced by a number of factors which includes age, body mass index (BMI), waist circumference (WC) and ethnicity. Aim: To study the relationship between anthropometric measurements and transabdominal measurements of prostate volume among male Residents in Ondo State. Method: A cross-sectional descriptive study was carried out at Ultrasound Department, University of Medical Sciences Teaching Hospital, Ondo, Ondo state with 200 healthy adults categorized into 4 age groups 1,2,3 and 4 i.e 20-50 years, 51-60 years, 61-70years, >71 years. Three categories of BMI was formed which are Healthy (18 to 25 kg/m2), Overweight (>25 to 29 kg/m2), Obese (≥30 kg/m2). Data analysis was done using SPSS version 20. Post hoc- LSD Fishers test was applied to make comparison between means of different groups. Univariate analysis was used to test the linear association among the variables. . P-value < 0.05 was considered significant. Results: Mean age of the subject in this study was 46.3 ± 17.0 years (Table 1). Age group was divided into group 1, 2, 3 and 4 i.e 20-50 years, 51-60 years, 61-70years, >71 years with 125, 29, 24 and 22 subjects respectively (Table 2). The BMI was classified into three groups which includes normal weight, over weight and obese with 100, 65 and 35 subjects respectively. The mean BMI in the study was 25.8 ± 4.61. Significant positive correlation was seen between prostrate volume and Age and positively with BMI. The correlation coefficients were (r=0.017) and (r=0.062) respectively. Conclusion: Age plays a significant role in the determination of prostate volume. The prostrate volume increases as the age increases. Also BMI has a contributing factor to change in prostate volume as the Obese people have an increase prostate volume.
References
Mitterberger M, Horninger W, Aiger F, Pinggera GM, Stephan I, Rehder P et al. Ultrasound of the Prostate. Cancer Imaging 2010; 10(1):40-48. Available in doi:10.1102/1470-7330.2010.0004.
Zia S-J, Cui D, and Jiang Q. An overview of prostate diseases and their characteristics specific to Asian men. Asian J Androl. 2012: 14(3):458-464. Available in doi:10.1038/aja.2010.137.
Marx FJ and Karenberg A. History of the Term Prostate. Prostate 2009; Vol 208-213
Naz Z, Anjum S. Effect of anthropometric measurements & personal data parameters on benign prostatic hyperplasia & carcinoma prostate. J Ayub Med Coll Abbottabad 2010; 22(3):54-57.
Ho EL, Tong SF and Tan HM. Prostate size: Is size all that matters? When does size matter? Journal of Men's Health 2011; 8(1):S22-S24. Available in https://doi.org/10.1016/S1875-6867(11)60014-6. 9
Berry SJ, Coffey DS, Walsh PC, Ewing LL. The development of human benign prostatic hyperplasia with age. The Journal of Urology1984; 132(3):474-479.
Forked JH, Motley SS, Cookson MS, Concepcion R, Chang SS, Wills MI et al. The Association between body size, prostate volume and prostate-specific antigen. Prostate Cancer and Prostatic Diseases 2007; 10:137-142.
Tsukamoto T, Masumori N, Nakagawa H, Arai Y, Komiya A, Ichikawa T, et al. Changes in prostate volume in Japanese patients with benign prostatic hyperplasia: association with other urological measures and risk of surgical intervention. International Journal of Urology 2009; 16(7):622-627.
Roehrborn CG. Benign prostatic hyperplasia: An overview. Reviews in urology2005; 7(Suppl 9):S3
Zhang SJ, Qian HN, Zhao Y, Sun K, Wang HQ, Liang GQ, et al. Relationship between age and prostate size. Asian Journal of Andrology 2013; 15(1):116
Tsukamoto T, Masumori N, Rahman M, Crane MM. Change in international prostate symptom score, prostrate-specific antigen and prostate volume in patients with benign prostatic hyperplasia followed longitudinally. International Journal of Urology. 2007; 14(4):321-324.
Baruah SK, Nath SJ, Puthenveetil RT, Baruah SJ, Deka PM, Bawri B. Correlation of age, prostate volume, serum prostatespecific antigen, and serum testosterone in indian, benign prostatic hyperplasia patients. UroToday Inter J 2012; 5:1-6.
Raza I, Hassan N, Gul P, Jafri A, Zehra N and Younas N. Determination of Prostate Gland Volume by Ultrasonography and Its Correlation with Anthropometric Measurements in a Subset of Karachi Population. British Journal of Medicine & Medical Research 2015; 11(9): 1-12.
Walz J, Graefen M, Chun FK, Erbersdobler A, Haese A, Steuben T, et al, High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series, Eur Urol. 2006; 50(3):498-505. Available in doi:10.1016/J.eururo.2006.03.026.
Rohrmann S, Smit E, Giovannucci E, Platz E. Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). International Journal of Obesity 2005; 29(3):310-316.
Burke JP, Rhodes T, Jacobson DJ, McGree ME, Roberts RO, Girman CJ, et al. Association of anthropometric measures with the presence and progression of benign prostatic hyperplasia. American Journal of Epidemiology 2006; 164(1):41-46.
Lee S, Min HG, Choi SH, Kim YJ, Oh SW, Kim YJ, et al. Central obesity as a risk factor for prostatic hyperplasia. Obesity 2006; 14(1):172-179.
Ogunbiyi JO, Shittu OB. Increased incidence of prostate cancer in Nigeria. J Natl Med Assoc. Mar 1999; 91(3);159-164.
Mohamme AZ, Edino ST, Ochicha O, Gwarzo AK, Samaila AA. Cancer in Nigeria: a 10-year analysis of the Kano cancer registry. Niger J Med. Jul-Aug 2008; 17(3):280-184.
Osegbe DN. Prostate cancer in Nigerians: facts and nonfacts. J Urol. Apr 1997; 157(4):1340-1343.
Badmus TA, Adesunkanmi AR, Yususf BM, et al. Burden of prostate cancer in southwestern Nigeria. Urology Aug 2010; 76(2):412-416.
Monowara M, Ahmed AU, Mohiuddin AS, Taher MA, Nasrin Z, Hossain MM. Correlation between transabdominal sonographically measured prostate volume with anthropometric factor in normal healthy subjects. BIRDEM Medical Journal 2012; 2(1):29-32.
Jeong CW, Park HK, Hong SK, Byun SS, Lee HJ, Lee SE. Comparison of prostate volume measured by transrectal ultrasonography and MRI with the actual prostate volume measured after radical prostatectomy. Urologia Internationalis 2008; 81(2):179-185.
Paterson NR, Lavallee LT, Nguyen LN, Witiuk K, Ross J, Malik R etc al. Prostate volume estimations using magnetic resonance imaging and transrectal ultrasound compared to radical prostatectomy specimens.Can Urology Assoc J. 2016; 10(7-8):264-268. 10
Ibinaiye PO, Adeyinka AO, Obajimi MO. Comparative evaluation of prostatic volume by transabdominal and transrectal ultrasonography in patients with prostatic hypertrophy in Ibadan. Eur J Sci Res 2005; 10:6-14.
Badmus TA, Asaleye CM, Badmus SA, Takure AO, Ibrahim MH, Arowolo OA. Benign prostate hyperplasia: Average volume in southwestern Nigerians and correlation with anthropometrics. Niger Postgrad Med J 2013; 20:52-56.
Mohammed A, Bello A, Maitama HY, Ajibola HO, Lawal AT, Isah MJ, et al. Determination of prostatic volume and characteristics by transrectal ultrasound among patients with lower urinary tract symptoms in Zaria Nigeria.Arch Int Surg 2014; 4:31-35.
Mosli HA and Abdel-Meguid TA. The Relationship Between Prostate Volume, Prostate Specific Antigen and Age in Saudi Men with Benign Prostatic Conditions. African Journal of Urology 2010; 16(4):117-123.
Dmochowski RR. Bladder outlet obstruction: Etiology and evaluation. Reviews in Urology2005; 7(Suppl 6):3-13.
Ayers K, Byrne LM, DeMatteo A, Brown NJ. Differential effects of nebivolol and metoprolol on insulin sensitivity and plasminogen activator inhibitor in the metabolic syndrome. Hypertension 2012; 59(4):893-8.
Platz E, Kawachi I, Rimm E, Longcope C, Stampfer M, Willett W, et al. Plasma steroid hormones, surgery for benign prostatic hyperplasia and severe lower urinary tract symptoms. Prostate Cancer Prostatic Dis 1999; 2:285-9.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 J. I. Fatukasi, S. E. Osho, S. O. Oyamakinde, A. Ogunsemoyin
This work is licensed under a Creative Commons Attribution 4.0 International License.
